33470757|t|Memantine protects blood-brain barrier integrity and attenuates neurological deficits through inhibiting nitric oxide synthase ser1412 phosphorylation in intracerebral hemorrhage rats: involvement of peroxynitrite-related matrix metalloproteinase-9/NLRP3 inflammasome activation.
33470757|a|Memantine has demonstrated beneficial effects on several types of brain insults via therapeutic mechanisms mainly related to its activity as a receptor antagonist of N-methyl-d-aspartate. However, the influences of memantine on intracerebral hemorrhage (ICH) remain obscure. This research probed into the neurovascular protective mechanisms of memantine after ICH and its impacts on neuronal nitric oxide synthase (nNOS) ser1412 phosphorylation. ICH model was established by employing intrastriatal collagenase injection in rats. After modeling, rats were then allocated randomly into sham-operated (sham), vehicle-treated (ICH+V), and memantine-administrated (ICH+M) groups. Memantine (20 mg/kg/day) was intraperitoneally administered 30 min after ICH and thenceforth once daily. Rats were dedicated at 0.25, 6, 12, 24 h, 3 and 7 d post-ICH for measurement of corresponding indexes. Behavioral changes, brain edema, levels of nNOS ser1412 phosphorylation, peroxynitrite, matrix metalloproteinase (MMP)-9, NLRP3, IL-1beta and numbers of dying neurons, as well as the cellular localization of gelatinolytic activity, were detected among the groups. Memantine improved the neurologic deficits and mitigated brain water content, levels of MMP-9, NLRP3, IL-1beta and dying neurons. Additionally, treatment with memantine also reduced nNOS ser1412 phosphorylation and peroxynitrite formation compared with the ICH+V group at 24 h after ICH. In situ zymography simultaneously revealed that gelatinase activity was primarily colocalized with vessel walls and neurons. We concluded that memantine ameliorated blood-brain barrier disruption and neurologic dysfunction in an ICH rat model. The underlying mechanism might involve repression of nNOS ser1412 phosphorylation, as well as peroxynitrite-related MMP-9 and NLRP3 inflammasome activation.
33470757	0	9	Memantine	Chemical	MESH:D008559
33470757	64	85	neurological deficits	Disease	MESH:D009461
33470757	127	134	ser1412	Chemical	-
33470757	154	178	intracerebral hemorrhage	Disease	MESH:D002543
33470757	179	183	rats	Species	10116
33470757	200	213	peroxynitrite	Chemical	MESH:D030421
33470757	222	248	matrix metalloproteinase-9	Gene	81687
33470757	249	254	NLRP3	Gene	287362
33470757	280	289	Memantine	Chemical	MESH:D008559
33470757	346	359	brain insults	Disease	MESH:D001927
33470757	446	466	N-methyl-d-aspartate	Chemical	MESH:D016202
33470757	495	504	memantine	Chemical	MESH:D008559
33470757	508	532	intracerebral hemorrhage	Disease	MESH:D002543
33470757	534	537	ICH	Disease	MESH:D002543
33470757	624	633	memantine	Chemical	MESH:D008559
33470757	640	643	ICH	Disease	MESH:D002543
33470757	663	693	neuronal nitric oxide synthase	Gene	24598
33470757	695	699	nNOS	Gene	24598
33470757	701	708	ser1412	Chemical	-
33470757	726	729	ICH	Disease	MESH:D002543
33470757	804	808	rats	Species	10116
33470757	826	830	rats	Species	10116
33470757	904	907	ICH	Disease	MESH:D002543
33470757	916	925	memantine	Chemical	MESH:D008559
33470757	941	944	ICH	Disease	MESH:D002543
33470757	956	965	Memantine	Chemical	MESH:D008559
33470757	1029	1032	ICH	Disease	MESH:D002543
33470757	1061	1065	Rats	Species	10116
33470757	1118	1121	ICH	Disease	MESH:D002543
33470757	1184	1195	brain edema	Disease	MESH:D001929
33470757	1207	1211	nNOS	Gene	24598
33470757	1212	1219	ser1412	Chemical	-
33470757	1237	1250	peroxynitrite	Chemical	MESH:D030421
33470757	1252	1284	matrix metalloproteinase (MMP)-9	Gene	81687
33470757	1286	1291	NLRP3	Gene	287362
33470757	1293	1301	IL-1beta	Gene	24494
33470757	1428	1437	Memantine	Chemical	MESH:D008559
33470757	1451	1470	neurologic deficits	Disease	MESH:D009461
33470757	1516	1521	MMP-9	Gene	81687
33470757	1523	1528	NLRP3	Gene	287362
33470757	1530	1538	IL-1beta	Gene	24494
33470757	1587	1596	memantine	Chemical	MESH:D008559
33470757	1610	1614	nNOS	Gene	24598
33470757	1615	1622	ser1412	Chemical	-
33470757	1643	1656	peroxynitrite	Chemical	MESH:D030421
33470757	1685	1688	ICH	Disease	MESH:D002543
33470757	1711	1714	ICH	Disease	MESH:D002543
33470757	1859	1868	memantine	Chemical	MESH:D008559
33470757	1916	1938	neurologic dysfunction	Disease	MESH:D009461
33470757	1945	1948	ICH	Disease	MESH:D002543
33470757	1949	1952	rat	Species	10116
33470757	2013	2017	nNOS	Gene	24598
33470757	2018	2025	ser1412	Chemical	-
33470757	2054	2067	peroxynitrite	Chemical	MESH:D030421
33470757	2076	2081	MMP-9	Gene	81687
33470757	2086	2091	NLRP3	Gene	287362
33470757	Negative_Correlation	MESH:D008559	MESH:D002543
33470757	Positive_Correlation	MESH:D030421	81687
33470757	Association	MESH:D030421	MESH:D002543
33470757	Negative_Correlation	MESH:D008559	MESH:D009461
33470757	Negative_Correlation	MESH:D008559	81687
33470757	Negative_Correlation	MESH:D008559	287362
33470757	Association	MESH:D030421	287362
33470757	Negative_Correlation	MESH:D008559	MESH:D001927
33470757	Negative_Correlation	MESH:D008559	MESH:D030421
33470757	Negative_Correlation	MESH:D008559	24598
33470757	Association	MESH:D002543	287362
33470757	Negative_Correlation	MESH:D008559	MESH:D016202
33470757	Negative_Correlation	MESH:D008559	24494
33470757	Association	MESH:D002543	81687

